“…Of these, the most common is the 550 kb microdeletion at 16p11.2 that is estimated to be present in 1% of patients with autism spectrum disorder (ASD) [Weiss et al, 2008]. Duplications involving 16p11.1p13.1 [Kirchhoff et al, 2005], 16p11.2p12.1 [Engelen et al, 2002;Bourthoumieu et al, 2008], 16p11.2p12.2 [Finelli et al, 2004;Pani et al, 2010;Tabet et al, 2012;Barber et al, 2013], 16p11.2p13.1 [Behjati et al, 2008], 16p12.1p12.2 [Ballif et al, 2007], and 16p12.2 [Marshall et al, 2008;Itsara et al, 2009] have also been reported in association with neurodevelopmental disorders, congenital anomalies, and dysmorphic features, suggesting that a number of dosage-sensitive genes reside in that region. There is a single report of triplication involving 16p12.1 in a patient with intellectual disability, dysmorphic facial features, short stature, and hypotonia [Ballif et al, 2007].…”